Research
Doctors and scientists at Mayo Clinic are studying ways to improve detection of recurrent prostate cancer, including new ways of using choline C-11 PET scans and new kinds of imaging tests. They also are studying new uses of this test for other conditions, such as hyperparathyroidism.
Cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Publications
See a list of publications about recurrent prostate cancer by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.